Autoliv, Inc. (ALV) At $142.33 Forms Top; Aevi Genomic Medicine (GNMX) SI Increased By 2.11%

Autoliv, Inc. (NYSE:ALV) Logo

Autoliv, Inc. (ALV) formed multiple top with $153.72 target or 8.00% above today’s $142.33 share price. Autoliv, Inc. (ALV) has $12.40 billion valuation. The stock increased 0.47% or $0.66 during the last trading session, reaching $142.33. About 254,713 shares traded. Autoliv, Inc. (NYSE:ALV) has risen 44.71% since May 14, 2017 and is uptrending. It has outperformed by 33.16% the S&P500.

Aevi Genomic Medicine Inc (NASDAQ:GNMX) had an increase of 2.11% in short interest. GNMX’s SI was 416,800 shares in May as released by FINRA. Its up 2.11% from 408,200 shares previously. With 128,400 avg volume, 3 days are for Aevi Genomic Medicine Inc (NASDAQ:GNMX)’s short sellers to cover GNMX’s short positions. It closed at $1.49 lastly. It is down 22.70% since May 14, 2017 and is uptrending. It has outperformed by 11.15% the S&P500.

Since February 15, 2018, it had 0 insider buys, and 4 sales for $379,045 activity. Mogefors Svante had sold 1,139 shares worth $164,927 on Wednesday, February 21. Lofvenholm Johan had sold 783 shares worth $113,378.

Among 29 analysts covering Autoliv Inc (NYSE:ALV), 9 have Buy rating, 8 Sell and 12 Hold. Therefore 31% are positive. Autoliv Inc has $19400 highest and $23 lowest target. $125.30’s average target is -11.97% below currents $142.33 stock price. Autoliv Inc had 111 analyst reports since July 22, 2015 according to SRatingsIntel. Longbow maintained it with “Buy” rating and $16800 target in Monday, April 30 report. The company was upgraded on Friday, July 31 by Credit Suisse. The rating was upgraded by Robert W. Baird to “Buy” on Wednesday, January 31. RBC Capital Markets maintained the shares of ALV in report on Monday, September 18 with “Hold” rating. The stock of Autoliv, Inc. (NYSE:ALV) has “Underperform” rating given on Friday, February 3 by RBC Capital Markets. The company was downgraded on Monday, April 18 by Goldman Sachs. The rating was downgraded by Robert W. Baird on Friday, October 28 to “Neutral”. Piper Jaffray maintained Autoliv, Inc. (NYSE:ALV) rating on Monday, July 24. Piper Jaffray has “Hold” rating and $9900 target. The stock has “Hold” rating by RBC Capital Markets on Friday, July 21. The firm has “Outperform” rating by Robert W. Baird given on Wednesday, January 27.

Investors sentiment decreased to 0.96 in Q4 2017. Its down 0.46, from 1.42 in 2017Q3. It dived, as 25 investors sold Autoliv, Inc. shares while 76 reduced holdings. 39 funds opened positions while 58 raised stakes. 28.56 million shares or 0.72% less from 28.77 million shares in 2017Q3 were reported. Walleye Trading Lc holds 0% of its portfolio in Autoliv, Inc. (NYSE:ALV) for 3,710 shares. Moreover, X Mgmt Ltd Liability Corporation has 0.01% invested in Autoliv, Inc. (NYSE:ALV). Hsbc Holding Public Ltd holds 0.01% or 30,506 shares in its portfolio. Cibc Asset Mgmt Inc has 4,728 shares for 0% of their portfolio. Northern Tru Corporation has invested 0.01% in Autoliv, Inc. (NYSE:ALV). State Street Corporation reported 0.01% in Autoliv, Inc. (NYSE:ALV). Regions Financial Corporation accumulated 306 shares or 0% of the stock. Rmb Capital Mgmt Ltd Limited Liability Company holds 5,728 shares. Moreover, Pension Service has 0.07% invested in Autoliv, Inc. (NYSE:ALV). Daiwa Incorporated, Japan-based fund reported 2,550 shares. Kbc Nv stated it has 15,524 shares. Sumitomo Mitsui Asset Mngmt Commerce Limited owns 0.01% invested in Autoliv, Inc. (NYSE:ALV) for 6,459 shares. Renaissance Technology Limited Liability reported 237,459 shares. D E Shaw & accumulated 0% or 12,404 shares. Winfield Assocs reported 0% in Autoliv, Inc. (NYSE:ALV).

Autoliv, Inc. (NYSE:ALV) Institutional Positions Chart